Zoetis Announces Dr. Richard Goldstein as Global Chief Medical Officer and Head of Medical Affairs

Dr. Mike McFarland to retire after 24 years of dedicated service

PARSIPPANY, N.J. - March 21, 2024 - Zoetis Inc. (NYSE:ZTS) today announced the appointment of Dr. Richard Goldstein, DVM, DACVIM, DECVIM-CA as Global Chief Medical Officer and Head of Medical Affairs for Zoetis, effective immediately. Goldstein is board certified by the American and European Colleges of Veterinary Internal Medicine and is an internationally recognized expert in companion animal medicine. He joined Zoetis in 2018 and currently serves as Vice President and Chief Medical Officer of Global Diagnostics.

Goldstein succeeds current Chief Medical Officer, Dr. Mike McFarland,DVM, DABVP, who will retire in June after 24 years of dedicated service. In this newly expanded role, Goldstein will be the foremost veterinary medical leader within Zoetis, providing medical guidance to leadership and fostering a unified direction among Zoetis' global veterinary community. He will also oversee the formation of a high-performing Global Medical Affairs team focused on modernizing medical operations and enhancing medical support globally.

"Richard Goldstein has been pivotal in driving innovation across the diagnostics portfolio, leading to improved disease diagnosis and better quality of life for pets. I'm confident he will bring that same drive to this new role to further strengthen our customer-first mindset and position Zoetis for continued success," said Rimma Driscoll, Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices for Zoetis.

Prior to Zoetis, Goldstein served as Chief Medical Officer of The Stephen & Christine Schwarzman Animal Center, the world's largest non-profit animal hospital. At The Animal Center, he was responsible for the oversight of all clinical activities and led a medical staff of over 80 veterinarians working across 17 specialized veterinary services in a 24/7 environment. He also oversaw the center's postgraduate education program. In addition, he was previously Associate Professor of Internal Medicine at Cornell University, College of Veterinary Medicine with a research focus on infectious, renal, and genetic diseases. During that time, he worked closely with Zoetis as an external key opinion leader where he contributed to the development and launch of many of the company's companion animal vaccines and parasiticides.

"Zoetis is a proven leader in developing innovative advancements in animal health, which is what led me to join the team six years ago," said Dr. Goldstein. "In this new role, I look forward to combining my leadership in the area of veterinary medicine with my background in research and education to further enhance our approach to animal care."

During his tenure at Zoetis, Mike McFarland was instrumental in driving strong connections between science and care, elevating the animal health industry and veterinarians in the process. As a co-founder for the International Veterinary Academy of Pain Management, he helped develop an in-depth certificate course on pain management for the World Small Animal Veterinary Association. He also co-founded the Human Animal Bond Research Institute, pioneering how the industry thinks about the transformative power of this bond.

About Dr. Richard Goldstein, DVM, DACVIM, DECVIM-CA

Dr. Richard Goldstein, board certified by the American and European Colleges of Veterinary Internal Medicine, is an internationally recognized expert in companion animal medicine. He previously served as the Chief Medical Officer of the Animal Medical Center in New York City and as an Associate Professor of Internal Medicine at Cornell University, College of Veterinary Medicine with a research focus on infectious, renal, and genetic diseases. Goldstein received his B.S. degree from the Institute of Biological Sciences, Hebrew University of Jerusalem, and his DVM from Koret School of Veterinary Medicine, Hebrew University of Jerusalem.

About Dr. Mike McFarland, DVM, DABVP

A veterinarian for over 35 years, McFarland intimately understands the nature of the human-animal bond and the dedication of veterinary professionals. He spent 15 years in private practice as a companion animal veterinarian in Dallas, including five years as the Medical Director for one of the country's first after-hours emergency practices, before joining the corporate world in 2000. As Chief Medical Officer, he played a pivotal role in strengthening Zoetis' customer obsession, ensuring that customers' voices were heard, and helped educate veterinarians worldwide on how to care for animals with today's advanced products.

McFarland serves on the Board of Directors for American Humane and is a Founder, and President, of the Board of Trustees for the Human Animal Bond Research Institute. He received undergraduate degrees in Animal Science and Veterinary Science from Texas A&M University and his DVM from the College of Veterinary Medicine at Texas A&M.

About Zoetis

As the world's leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide - from veterinarians and pet owners to livestock farmers and ranchers. The company's leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with approximately 14,100 employees. For more information, visit www.zoetis.com.

Public link

Please use the above public link if you want to share this noodl on another website.